Dr. Maximilian Zellerhoff

Life Sciences & Healthcare

• Veloxis Pharmaceuticals, US subsidiary of Japanese conglomerate Ashai Kasei, on its EUR 780m acquisition of AiCurisAnti-infective Cures AG
• Permira and Nordic Capital on the intended acquisition of Bavarian Nordic A/S
• BIOTRONIK Group, a leading global medical technology company based in Berlin, Germany, on an agreement to divest its Vascular Intervention (‘VI’) division to Teleflex Incorporated, a global provider of medical technologies
• Merck on its acquisition of HUB Organoids Holding B.V. from Stichting Ontwikkelfonds voor Organoïden
• Eppendorf on the sale of its micro manipulation product portfolio to Calibre Scientific
• Grünenthal on a joint venture collaboration with Kyowa Kirin International, the Japan-based global specialty pharmaceutical company, in relation to Kyowa Kirin's established drug portfolio of 13 brands across six therapeutic areas with a focus on pain management
• International Chemical Investors Group (ICIG) on their sale of CordenPharma, a leading global contract development & manufacturing organization (CDMO), to European private equity firm Astorg
• International chemicals company LANXESS on its $1,3bn acquisition of the Microbial Control business of International Flavors & Fragrances (IFF)
• Grünenthal on its acquisition of the men's health product Nebido for a purchase price of up to € 500m from Bayer AG
• Grünenthal on its acquisition of Mestex AG
• International pharmaceutical and biotechnology company AstraZeneca on its $39bn acquisition of Alexion Pharmaceuticals
• International chemicals company LANXESS on its acquisition of Theseo Group, a manufacturer of disinfectant and hygiene solutions
• Private equity investor Charterhouse Capital Partners / SERB on the $800m acquisition of the BTG Specialty Pharmaceuticals business from Boston Scientific Corporation

Technology

• Accenture on the acquisition of Sentia Group's business in the Netherlands, Bulgaria and Belgium. The Sentia Group provides cloud advisory and delivery services
• Private equity investor EQT on the sale of Utimaco Verwaltungs GmbH, one of the leading global providers of mission-critical professional cybersecurity and data intelligence solutions for regulated critical infrastructures
• Private equity investor Francisco Partners on the acquisition of a majority of the shares in Native Instruments Holding GmbH, the Berlin-based global leader in digital music creation software and hardware

Other

• TPG Real Estate Partners on acquiring a real estate portfolio for approx. €400 million before adjustments from Canada’s Northwest Healthcare Properties Real Estate Investment Trust
• Continental on spin-off and stock exchange listing of AUMOVIO SE
• Cinven on the Sale of Viridium Group to a consortium comprising Allianz, BlackRock, T&D Holdings, HannoverRE and Generali
• Schenck Process Group on the $730M sale of its Food and Performance Materials Business to Hillenbrand
• Röhm on the acquisition of SABIC's worldwide polycarbonate business
• Prettl Group and private equity investor Trilantic Europe on the sale of Prettl SWH Group, a developer and manufacturer of sensor, connectivity and electrification solutions for the automotive industry, to Foxconn Interconnect Technology
• Viridium on the acquisition of an extensive portfolio of traditional life insurance policies with approximately 720,000 insurance contracts and assets under management of approximately €21 billion from Zurich Group Germany
• Continental, a leading automotive manufacturing company, on the carve-out of its powertrain business ("Vitesco Technologies")
• Merck KGaA on the restructuring and repositioning of its Gernsheim production site
• Global investment banking firm Goldman Sachs on its acquisition of Oikos Group, one of Europe's leading providers of prefabricated houses